Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFR2/CD309 anticorps (Soluble)

Cet anticorps Lapin Polyclonal détecte spécifiquement VEGFR2/CD309 dans WB. Il présente une réactivité envers Souris.
N° du produit ABIN1589863

Aperçu rapide pour VEGFR2/CD309 anticorps (Soluble) (ABIN1589863)

Antigène

Voir toutes VEGFR2/CD309 (VEGFR2) Anticorps
VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Reactivité

  • 318
  • 204
  • 139
  • 17
  • 10
  • 5
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Souris

Hôte

  • 286
  • 65
  • 37
  • 3
  • 1
  • 1
  • 1
  • 1
Lapin

Clonalité

  • 276
  • 119
Polyclonal

Conjugué

  • 173
  • 34
  • 19
  • 13
  • 11
  • 9
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Cet anticorp VEGFR2/CD309 est non-conjugé

Application

  • 213
  • 117
  • 115
  • 114
  • 63
  • 28
  • 26
  • 26
  • 22
  • 15
  • 13
  • 13
  • 9
  • 7
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Épitope

    • 38
    • 33
    • 26
    • 23
    • 20
    • 16
    • 16
    • 11
    • 11
    • 10
    • 9
    • 9
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Soluble

    Fonction

    VEGFR-2/Flk-1 (Peptide), soluble antibody

    Specificité

    Peptide: GMEASLGDRIAMP

    Attributs du produit

    Chromosomal location: 5 C3.3, 5 42.0 cM
    Produced from sera of rabbits immunised with a peptide of the C-terminal end of native mouse soluble VEGFR-2/Flk-1 (GMEASLGDRIAMP).

    Purification

    Anti-human soluble VEGFR-2/KDR was purified by affinity chromatography with immobilized Protein A.

    Immunogène

    Peptide: GMEASLGDRIAMP

    Isotype

    IgG
  • Indications d'application

    Western Blot: use at 1-5 μg/mL.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Centrifuge vial prior to opening. Reconstitute in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS

    Conseil sur la manipulation

    Centrifuge vial prior to opening.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    The lyophilized antibody is stable for at least 2 years at -20°C. After sterile reconstitution the antibody is stable at 2-8°C for up to 6 months. Frozen aliquots are stable for at least 6 months when stored at -20°C. Addition of a carrier protein or 50% glycerol is recommended for frozen aliquots.

    Date de péremption

    24 months
  • Antigène

    VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

    Autre désignation

    VEGFR-2/Flk-1

    Sujet

    Soluble vascular endothelial growth factor receptor-2 , soluble Kdr, soluble Ly73, soluble Flk-1, sVEGFR2, sVEGF receptor 2, soluble kinase insert domain protein receptor,The antibody recognizes solely the endogenous soluble form of mouse vascular endothelial growth factor receptor 2, alos known as CD309, VEGFR2, KDR, protein tyrosine kinase receptor flk-1, and fetal liver kinase-1. The endogenous soluble mouse esFlk-1 generated by alternative splicing consists of the first 6 Ig-like loops followed by the unique C-terminal end: GMEASLGDRIAMP. Flk-1 is a member of the tyrosine protein kinase family, sub-family CSF-1/PDGF, that contains a single pass transmembrane receptor with a protein kinase domain and seven immunoglobulin-like domains in the extracellular region. Flk-1 is expressed at high levels in adult heart, lung, kidney, brain, and skeletal muscle, other tissues express at lower levels. Flk-1 is a receptor for VEGF-A or fully processed VEGF-C, ligand binding plays a key role in vascular development and vascular permeability.

    ID gène

    16542

    UniProt

    P35918

    Pathways

    Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Vous êtes ici:
Chat with us!